Search

Your search keyword '"Al-Kassou, Baravan"' showing total 215 results

Search Constraints

Start Over You searched for: Author "Al-Kassou, Baravan" Remove constraint Author: "Al-Kassou, Baravan"
215 results on '"Al-Kassou, Baravan"'

Search Results

12. C-Reactive Protein to Albumin Ratio in Patients Undergoing Transcatheter Aortic Valve Replacement

15. Cholesterol Crystal Dissolution Rate of Serum Predicts Outcomes in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

18. Transcatheter Replacement of Transcatheter Versus Surgically Implanted Aortic Valve Bioprostheses

19. Risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 German patients

21. Quantitative Assessment of Acute Regurgitation Following TAVR: A Multicenter Pooled Analysis of 2,258 Valves

27. Impact of transradial versus transfemoral access for preprocedural coronary angiography on TAVR-associated complications

31. Echocardiographic Progression of Calcific Aortic Valve Disease in Patients with Preexisting Aortic Valve Sclerosis.

34. Impact of different guidewires on the implantation depth using the largest self-expandable TAVI device

36. Echocardiographic progression of calcific aortic valve disease in patients with preexisting aortic valve sclerosis

37. Transcatheter aortic valve implantation with different self-expanding devices—a propensity score-matched multicenter comparison

38. The lncRNA MRPL20-AS1 is associated with severe OSAS and downregulated upon hypoxic injury of endothelial cells

39. Optimal protamine‐to‐heparin dosing ratio for the prevention of bleeding complications in patients undergoing TAVR—A multicenter experience

40. Mortality prediction of the frailty syndrome in patients with severe mitral regurgitation

41. A simplified cardiac damage staging predicts the outcome of patients undergoing TAVR—A multicenter analysis

42. Outcomes of Redo Transcatheter Aortic Valve Replacement According to the Initial and Subsequent Valve Type

43. Optimal Protamine-to-Heparin Dosing Ratio for the Prevention of Bleeding Complications in Patients Undergoing TAVR – A Multicenter Experience

44. Longer leukocyte telomere length is associated with myeloid inflammation and increased mortality after transcatheter aortic valve replacement

45. Impact of Transradial Versus Transfemoral Artery Approach for Pre-Procedural Coronary Angiography on Outcomes in Patients Undergoing Subsequent TAVR

46. Elucidation of the genetic causes of bicuspid aortic valve disease

47. Elucidation of the genetic causes of bicuspid aortic valve disease.

48. Optimal protamine‐to‐heparin dosing ratio for the prevention of bleeding complications in patients undergoing TAVR—A multicenter experience.

49. Baseline PA/BSA ratio in patients undergoing transcatheter aortic valve replacement – A novel CT-based marker for the prediction of pulmonary hypertension and outcome

50. Haemodynamic differences between two generations of a balloon-expandable transcatheter heart valve

Catalog

Books, media, physical & digital resources